Femasys (FEMY) vs Polyrizon (PLRZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Polyrizon (PLRZ) has outperformed Femasys (FEMY) over the past year, gaining 38.6% versus a loss of 86.6%. Polyrizon is the larger company by market cap ($21.5 million vs $17.2 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FEMY | PLRZ |
|---|---|---|
| Share price | $2.05 | $8.87 |
| Market cap | $17.17M | $21.55M |
| 1-day change | +2.49% | -3.03% |
| YTD return | -82.64% | +7.77% |
| 1-year return | -86.61% | +38.64% |
| 5-year return | -98.57% | — |
| EPS (TTM) | $-3.28 | $-4.97 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $22.20 | $18.20 |
| 52-week low | $1.94 | $2.88 |
| Distance from 52-week high | -90.77% | -51.25% |
| Average volume | 721.18K | 60.52K |
| Shares outstanding | 8.38M | 2.43M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PLRZ has outperformed FEMY by 125.2 percentage points over the past year.
FEMY vs PLRZ FAQ
Which is bigger, Femasys or Polyrizon?
Polyrizon (PLRZ) is larger, with a market capitalization of $21.55M compared with $17.17M for Femasys (FEMY).
Which stock has performed better over the past year, FEMY or PLRZ?
PLRZ returned +38.64% over the past 12 months, compared with -86.61% for FEMY (price return, excluding dividends). Past performance does not predict future results.
Are Femasys and Polyrizon in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.